MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 10 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 2,477.11

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016BarclaysBoost Price TargetOverweightGBX 2,760 -> GBX 2,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Jefferies GroupReiterated RatingBuyGBX 2,355View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 2,500 -> GBX 2,300View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016HSBCReiterated RatingBuyGBX 2,525View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016AlphaValueReiterated RatingBuyGBX 2,554View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Stifel NicolausReiterated RatingBuyGBX 2,400View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Shore CapitalUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha